WE WILL NO LONGER BE COLLAPSING THE ARTICLES BECAUSE READING THEM IS NO LONGER OPTIONAL. SHARE YOUR THOUGHTS & HOW HAPPY YOU ARE FOR THE MAN TREATED FOR CUTANEOUS MELANOMA but on a serious note, what kinds of cancer treatment are most likely to be successful first? how can I gamble on it?

PDF

Russia and Cuba announced a significant strengthening of their scientific cooperation through the signing of a memorandum of understanding for the joint development of cancer vaccines. The signing took place during the 23rd session of the Russian-Cuban Intergovernmental Commission for Economic, Trade, and Scientific-Technical Cooperation, held in St. Petersburg.

RELATED: Russia Prepares Second Oil Shipment to Cuba 😎

Russian Deputy Prime Minister Dmitry Chernyshenko emphasized the importance of this collaboration for advancing one of the most challenging fields in modern medicine. “This alliance demonstrates our shared commitment to the health and well-being of our people,” he stated during the official ceremony. During the meeting, Kira Zaslavskaya, head of the Russian pharmaceutical group Promomed, detailed the terms of the agreement, which is formalized through a memorandum of understanding with the Cuban company BioCubaFarma.

The central objective is to create a unique, multi-target cancer vaccine that combines the expertise of both nations. “We are establishing a priority relationship with Cuba in the fight against cancer,” Zaslavskaya emphasized.

The collaboration between Promomed and BioCubaFarma seeks to integrate Russia’s cutting-edge technology with Cuba’s renowned expertise in biotechnology and the development of complex medications.

This synergy aims to accelerate the creation of new therapies that can benefit not only the populations of both countries but also represent a significant contribution to global medicine.

The announcement comes amid significant advances for Russia in the field of cancer immunotherapy. Recently, the Russian Ministry of Health reported the first administration of its personalized cancer vaccine, Neooncovac.

A 60-year-old man with cutaneous melanoma became the first patient to receive this innovative treatment, reinforcing the technical expertise that Russia brings to this strategic alliance.

The text reads, “Our country attaches special importance to relations with the Eurasian Economic Union, and recognizes the broad prospects for cooperation in medicine and the biopharmaceutical industry, energy, transport and the agri-food industry.” The intergovernmental session, co-chaired by Dmitry Chernyshenko and Cuban Deputy Prime Minister Oscar Pérez-Oliva, concluded with positive results, as highlighted on social media by Cuban Prime Minister Manuel Marrero. The meeting was characterized by a fruitful and positive dialogue, with both sides agreeing on the need to expand and strengthen economic and trade ties.

The Prime Minister emphasized the Cuban side’s gratitude to the Russian government and people for their expressions of solidarity and support amidst the complex economic scenario resulting from the restrictive measures imposed by the United States. Pérez-Oliva, who also serves as Minister of Foreign Trade and Foreign Investment, met with the governors of St. Petersburg and Leningrad to deepen cooperation in key sectors.

In the health sector, the Cuban delegation held discussions with Mikhail Murashko, Russia’s Minister of Health. At the conclusion of the meeting, a memorandum of understanding was signed between the Cuban State Center for the Control of Medicines and Medical Equipment (CECMED) and the Scientific Center for Expertise in Medical Products of the Russian Ministry of Health, establishing a joint regulatory framework for future developments.

Cooperation in biotechnology between Russia and Cuba is positioned as a strategic axis for access to innovative cancer therapies, in a global context where joint research and the exchange of scientific knowledge are becoming increasingly important for addressing complex health challenges.